EX-2.1 2 dex21.htm STOCK PURCHASE AGREEMENT STOCK PURCHASE AGREEMENT between: XCYTE THERAPIES, INC., a Delaware corporation; and CYCLACEL GROUP PLC, a public limited company organized under the laws of England and Wales. Dated as of December 15, 2005...Stock Purchase Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionTHIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of December 15, 2005, by and between XCYTE THERAPIES, INC., a Delaware corporation (“Xcyte”), and CYCLACEL GROUP PLC, a public limited company organized under the laws of England and Wales with registered number 5090795 (“Seller”). Certain capitalized terms used in this Agreement are defined in Exhibit A.
STOCK PURCHASE AGREEMENT between: XCYTE THERAPIES, INC., a Delaware corporation; and CYCLACEL GROUP PLC, a public limited company organized under the laws of England and Wales.Stock Purchase Agreement • December 20th, 2005 • Xcyte Therapies Inc • Pharmaceutical preparations • Delaware
Contract Type FiledDecember 20th, 2005 Company Industry JurisdictionTHIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of December 15, 2005, by and between XCYTE THERAPIES, INC., a Delaware corporation (“Xcyte”), and CYCLACEL GROUP PLC, a public limited company organized under the laws of England and Wales with registered number 5090795 (“Seller”). Certain capitalized terms used in this Agreement are defined in Exhibit A.